Cambrex Starts 120M Iowa Plant Expansion
Pharmaceutical manufacturer Cambrex has started a 120 million dollar expansion at its Iowa plant. The project will increase manufacturing capacity by 25 percent and finish in 2028.
Cambrex has broken ground on a $120 million expansion of its Charles City plant in the United States, increasing manufacturing capacity by 25%. The 45-acre facility marks its 100th anniversary with the project, slated for completion in late 2028. The investment bolsters domestic production of active pharmaceutical ingredients, including regulated narcotics.
